Two Seas Capital LP
Two Seas Capital LP's Two Seas Capital LP holds 40 U.S.-equity positions worth $7.2B (SEC 13F, Q1 2026). Top positions: State Str Spdr S&p 500 Etf T 58.8%, Core Scientific, Inc. Common Stock 4.3%, Roivant Sciences Ltd. Common Shares 3.9%. 13F-replication return is +138% over 3 years (+74 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| SPY State Str Spdr S&p 500 Etf T | 58.8% | 6.5M | $4.2B | ▲ 74% (+2.8M) | $620.85 | $747.03 (+20%) | 2026-03-31 |
| CORZ Core Scientific, Inc. Common Stock | 4.3% | 20.7M | $309M | ▼ 20% (−5.0M) | $13.12 | $20.72 (+58%) | 2026-03-31 |
| ROIV Roivant Sciences Ltd. Common Shares | 3.9% | 10.1M | $279M | ▼ 18% (−2.2M) | $10.27 | $33.91 (+230%) | 2026-03-31 |
| XBI Spdr Series Trust | 3.4% | 1.9M | $246M | NEW (+1.9M) | $127.73 | $147.01 (+15%) | 2026-03-31 |
| AAPL Apple Inc. | 3.0% | 850K | $216M | NEW (+850K) | $253.79 | $308.91 (+22%) | 2026-03-31 |
| CLMT Calumet, Inc. Common Stock | 3.0% | 6.0M | $214M | ▼ 26% (−2.1M) | $18.40 | $44.19 (+140%) | 2026-03-31 |
| TLN Talen Energy Corporation Common Stock | 2.6% | 579K | $185M | ▲ 48% (+187K) | $271.74 | $334.10 (+23%) | 2026-03-31 |
| FSLR First Solar, Inc. | 2.1% | 762K | $150M | ▲ 168% (+477K) | $185.42 | $211.03 (+14%) | 2026-03-31 |
| INDV Indivior Pharmaceuticals, Inc. Common Stock | 2.0% | 4.7M | $145M | NEW (+4.7M) | $30.48 | $40.01 (+31%) | 2026-03-31 |
| NKTR Nektar Therapeutics | 2.0% | 2.0M | $141M | ▲ 163% (+1.2M) | $60.66 | $70.67 (+16%) | 2026-03-31 |
| TDAY USA TODAY Co., Inc. | 1.4% | 14.0M | $99M | ▼ 3.5% (−507K) | $5.15 | $8.69 (+69%) | 2026-03-31 |
| SOC Sable Offshore Corp. | 1.3% | 5.5M | $91M | ▲ 217% (+3.8M) | $17.14 | $5.29 (−69%) | 2026-03-31 |
| SATS EchoStar Corporation | 1.2% | 757K | $89M | ▲ 88% (+355K) | $100.13 | — (+17%) | 2026-03-31 |
| SHC Sotera Health Company Common Stock | 1.2% | 6.0M | $86M | ▲ 37% (+1.6M) | $14.11 | $17.86 (+27%) | 2026-03-31 |
| ABUS Arbutus Biopharma Corporation Common Stock | 1.2% | 18.6M | $84M | ▲ 47% (+6.0M) | $3.68 | $4.34 (+18%) | 2026-03-31 |
| GLNG Golar LNG Ltd | 1.1% | 1.5M | $83M | ▲ 30% (+354K) | $42.81 | $49.15 (+15%) | 2026-03-31 |
| IMVT Immunovant, Inc. Common Stock | 1.1% | 3.2M | $80M | ▲ 12% (+335K) | $23.29 | $38.62 (+66%) | 2026-03-31 |
| FTAI FTAI Aviation Ltd. Common Stock | 0.9% | 256K | $63M | ▲ 37% (+69K) | $161.75 | $206.00 (+27%) | 2026-03-31 |
| WULF TeraWulf Inc. Common Stock | 0.8% | 4.0M | $58M | ▼ 11% (−479K) | $7.86 | $17.66 (+125%) | 2026-03-31 |
| MRNA Moderna, Inc. Common Stock | 0.8% | 1.1M | $56M | NEW (+1.1M) | $50.80 | $54.82 (+8%) | 2026-03-31 |
| ESPR Esperion Therapeutics, Inc. | 0.4% | 11.4M | $31M | ▼ 4.3% (−508K) | $1.75 | — (+57%) | 2026-03-31 |
| VST Vistra Corp. | 0.4% | 186K | $28M | ▼ 26% (−64K) | $120.86 | $148.19 (+23%) | 2026-03-31 |
| CIFR Cipher Digital Inc. Common Stock | 0.4% | 2.0M | $26M | ▲ 570% (+1.7M) | $12.20 | $22.32 (+83%) | 2026-03-31 |
| QURE uniQure N.V. | 0.3% | 1.3M | $21M | NEW (+1.3M) | $16.35 | $43.63 (+167%) | 2026-03-31 |
| TAC TransAlta Corporation | 0.3% | 1.6M | $21M | NEW (+1.6M) | $13.10 | $12.50 (−5%) | 2026-03-31 |
| NBIS Nebius Group N.V. Class A Ordinary Shares | 0.3% | 196K | $20M | ▼ 43% (−148K) | $50.41 | $190.41 (+278%) | 2026-03-31 |
| MSOS Advisorshares Tr | 0.3% | 5.5M | $20M | ▼ 19% (−1.3M) | $4.77 | $4.23 (−11%) | 2026-03-31 |
| STAA Staar Surgical Co | 0.3% | 1.0M | $19M | NEW (+1.0M) | $18.70 | $24.36 (+30%) | 2026-03-31 |
| BTDR Bitdeer Technologies Group Class A Ordinary Shares | 0.3% | 2.2M | $19M | NEW (+2.2M) | $11.25 | $10.52 (−6%) | 2026-03-31 |
| IBIT Ishares Bitcoin Trust Etf | 0.3% | 500K | $19M | ▼ 59% (−718K) | $49.65 | $35.64 (−28%) | 2026-03-31 |
| SONO Sonos, Inc. Common Stock | 0.2% | 919K | $12M | ▲ 185% (+597K) | $14.35 | $14.66 (+2%) | 2026-03-31 |
| HUT Hut 8 Corp. Common Stock | 0.2% | 250K | $12M | ▼ 89% (−2.0M) | $44.24 | $107.63 (+143%) | 2026-03-31 |
| SHAZ SharonAI Holdings, Inc. Class A Common Stock | 0.1% | 417K | $9M | NEW (+417K) | $22.73 | $48.25 (+112%) | 2026-03-31 |
| PAVM PAVmed Inc. Common Stock | 0.1% | 462K | $5M | NEW (+462K) | $10.15 | $4.95 (−51%) | 2026-03-31 |
| OMEX Odyssey Marine Exploration, Inc | 0.1% | 5.6M | $5M | ▲ 7.9% (+408K) | $1.58 | $0.60 (−62%) | 2026-03-31 |
| LUCD Lucid Diagnostics Inc. Common Stock | 0.1% | 3.0M | $3M | — | $1.01 | $0.87 (−14%) | 2026-03-31 |
| CORZW Core Scientific Inc New | 0.0% | 290K | $3M | — | $2.94 | $14.00 (+376%) | 2026-03-31 |
| DAR DARLING INGREDIENTS INC. | 0.0% | 17K | $1M | NEW (+17K) | $61.85 | $60.64 (−2%) | 2026-03-31 |
| CORZZ Core Scientific Inc New | 0.0% | 24K | $362K | — | $2.45 | $21.16 (+765%) | 2026-03-31 |
| FRMI Fermi Inc. Common Stock | 0.0% | 25K | $147K | NEW (+25K) | $5.84 | $5.69 (−3%) | 2026-03-31 |
FAQ ▾
What are Two Seas Capital LP's largest holdings?
As of the latest 13F: State Str Spdr S&p 500 Etf T 58.8%, Core Scientific, Inc. Common Stock 4.3%, Roivant Sciences Ltd. Common Shares 3.9%, Spdr Series Trust 3.4%, Apple Inc. 3.0%.
How big is Two Seas Capital LP's 13F portfolio?
$7.2B across 40 disclosed U.S.-equity positions.
What is Two Seas Capital LP's 3-year performance?
+138% (13F-replication, price return), +74 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.